Squarepoint’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-232,384
| Closed | -$13.4M | – | 4584 |
|
|
2025
Q2 | $13.7M | Buy |
232,384
+203,985
| +718% | +$13.2M | 0.01% | 933 |
|
|
2025
Q1 | $2.08M | Buy |
+28,399
| New | +$2.35M | ﹤0.01% | 2064 |
|
|
2024
Q4 | – | Sell |
-27,769
| Closed | -$1.99M | – | 5188 |
|
|
2024
Q3 | $1.99M | Buy |
27,769
+6,287
| +29% | +$444K | ﹤0.01% | 2075 |
|
|
2024
Q2 | $1.47M | Sell |
21,482
-134,319
| -86% | -$8.02M | ﹤0.01% | 2281 |
|
|
2024
Q1 | $8.36M | Sell |
155,801
-31,795
| -17% | -$1.71M | 0.01% | 1108 |
|
|
2023
Q4 | $10M | Sell |
187,596
-58,798
| -24% | -$2.87M | 0.02% | 951 |
|
|
2023
Q3 | $12.2M | Buy |
246,394
+85,630
| +53% | +$4.79M | 0.03% | 703 |
|
|
2023
Q2 | $9.57M | Sell |
160,764
-67,400
| -30% | -$3.84M | 0.03% | 702 |
|
|
2023
Q1 | $12.9M | Buy |
+228,164
| New | +$14.6M | 0.05% | 446 |
|
|
2022
Q4 | – | Sell |
-19,660
| Closed | -$1.17M | – | 3334 |
|
|
2022
Q3 | $1.17M | Buy |
+19,660
| New | +$1.18M | 0.01% | 1656 |
|
|
2022
Q2 | – | Sell |
-24,015
| Closed | -$1.77M | – | 3055 |
|
|
2022
Q1 | $1.77M | Sell |
24,015
-24,368
| -50% | -$1.69M | 0.01% | 1230 |
|
|
2021
Q4 | $3.49M | Buy |
48,383
+20,079
| +71% | +$1.46M | 0.01% | 954 |
|
|
2021
Q3 | $2.17M | Buy |
+28,304
| New | +$2.27M | 0.01% | 1167 |
|
|
2021
Q2 | – | Sell |
-9,415
| Closed | -$581K | – | 3403 |
|
|
2021
Q1 | $581K | Sell |
9,415
-29,199
| -76% | -$1.85M | ﹤0.01% | 1908 |
|
|
2020
Q4 | $2.52M | Sell |
38,614
-5,770
| -13% | -$332K | 0.02% | 821 |
|
|
2020
Q3 | $2.2M | Sell |
44,384
-53,069
| -54% | -$2.74M | 0.03% | 618 |
|
|
2020
Q2 | $4.65M | Buy |
+97,453
| New | +$4.7M | 0.08% | 359 |
|
|
2020
Q1 | – | Sell |
-90,703
| Closed | -$5.34M | – | 2112 |
|
|
2019
Q4 | $5.34M | Buy |
90,703
+78,603
| +650% | +$4.27M | 0.03% | 487 |
|
|
2019
Q3 | $619K | Buy |
+12,100
| New | +$576K | 0.01% | 1507 |
|
|
2019
Q1 | – | Sell |
-128,042
| Closed | -$5.54M | – | 2255 |
|
|
2018
Q4 | $5.54M | Buy |
128,042
+121,412
| +1,831% | +$6.06M | 0.06% | 380 |
|
|
2018
Q3 | $376K | Buy |
+6,630
| New | +$349K | ﹤0.01% | 1439 |
|
|
2018
Q2 | – | Sell |
-7,397
| Closed | -$369K | – | 1861 |
|
|
2018
Q1 | $369K | Sell |
7,397
-7,052
| -49% | -$331K | 0.01% | 1216 |
|
|
2017
Q4 | $594K | Sell |
14,449
-4,528
| -24% | -$159K | 0.01% | 1100 |
|
|
2017
Q3 | $564K | Buy |
18,977
+4,948
| +35% | +$151K | 0.01% | 935 |
|
|
2017
Q2 | $465K | Sell |
14,029
-31,080
| -69% | -$976K | 0.01% | 984 |
|
|
2017
Q1 | $1.34M | Buy |
45,109
+16,926
| +60% | +$462K | 0.04% | 504 |
|
|
2016
Q4 | $699K | Buy |
+28,183
| New | +$640K | 0.03% | 656 |
|
Other funds holding GMED
VCM
VPM
SC
Squarepoint's GMED Position: Q3 2025 in Review
Squarepoint sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 232,384 shares — an estimated $13.4M sold.
Squarepoint first reported a position in GMED in Q4 2016 and held it in 27 quarters. The position peaked at $13.7M in Q2 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.
- Squarepoint reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
- Squarepoint sold 232,384 Globus Medical shares in Q3 2025, an estimated $13.4M.
- Squarepoint first reported a position in Globus Medical in Q4 2016 and held it in 27 quarters.
- Squarepoint's Globus Medical position peaked at $13.7M in Q2 2025.
- 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.
Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.